Pharmacological Properties of Fidarestat, a Potent Aldose Reductase Inhibitor, Clarified by Using Sorbitol in Human and Rat Erythrocytes

Publisher： Karger

E-ISSN： 1423-0313|62|4|193-199

ISSN： 0031-7012

Source： Pharmacology, Vol.62, Iss.4, 2001-05, pp. : 193-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Aldose Reductase Inhibitor Fidarestat Suppresses Ischemia-Reperfusion-Induced Inflammatory Response in Rat Retina

By  

Pharmacology, Vol. 84, Iss. 5, 2009-09 ,pp. : 257-263

Karger

Access to resources Recommend Favorite

Binding of Fidarestat Stereoisomers with Aldose Reductase

By Kim Dooil   Hong Suk-In   Lee Dae-Sil  

International Journal of Molecular Sciences, Vol. 7, Iss. 11, 2006-11 ,pp. : 519-536

MDPI

Access to resources Recommend Favorite

Pharmacological Properties of the Gastric H+/K+ ATPase Inhibitor, AU-461

By  

Pharmacology, Vol. 60, Iss. 3, 2000-04 ,pp. : 161-168

Karger

Access to resources Recommend Favorite

Oxoisoaporphine as Potent Telomerase Inhibitor

By Wei Zu-Zhuang   Qin Qi-Pin   Chen Jia-Nian   Chen Zhen-Feng  

Molecules, Vol. 21, Iss. 11, 2016-11 ,pp. : 1534-1534

MDPI

Access to resources Recommend Favorite

Inhibitory Effects of Colocasia esculenta (L.) Schott Constituents on Aldose Reductase

By Li Hong Mei   Hwang Seung Hwan   Kang Beom Goo   Hong Jae Seung   Lim Soon Sung  

Molecules, Vol. 19, Iss. 9, 2014-08 ,pp. : 13212-13224

MDPI

Access to resources Recommend Favorite